50 employees
Novelos Therapeutics, Inc. (Novelos) is a biopharmaceutical company focused on developing and commercializing oxidized glutathione-based
1996
$9M
from 1 investors over 1 rounds
Novelos Therapeutics raised $9M on November 19, 2009
Investors: Advantage Capital